dpp 4 inhibitor glp 1 agonist Role of Dipeptidyl Peptidase Inhibitors in Antidiabetic Treatment Inhibition of DPP-4. Food consumption
Description
MacDonald PE, El-Kholy W, Riedel MJ, Salapatek AM, Light PE, Wheeler MB

They were found to have significant HbA1c, and weight reduction compared to placebo in patients with diabetes and obesity respectively

Acute Pancreatitis: Based on spontaneous postmarketing reports, acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with liraglutide

Interestingly, AD has been associated with a dysfunction in insulin signaling in the brain

Dulaglutide is approved for T2DM management (Sanford, 2014), offering glycemic control and weight loss benefits comparable to liraglutide but with the added convenience of a weekly dosing regimen (Chang et al., 2020)
